(6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; (5'?,10?)-2'-Ethyl-9,10-dihydro-12'-hydroxy-5'-(phenylmethyl)-ergotaman-3',6',18-trione; DE 145; Dihydroergostine; Indolo[4,3-fg]quinoline, Ergotaman-3',6',18-trione Deriv.; Dihydro Ergotamine Mesylate EP Impurity B
Dihydro Ergotamine Mesylate Impurity B ((9,10-Dihydroergostine) is a fully characterized chemical compound used as a reference standard of API Ergotamine. The standard offered is compliant with regulatory guidelines. Dihydro Ergotamine Mesylate Impurity B ((9,10-Dihydroergostine) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 3609-19-6